Fundraising Fox
🦊/Companies
Sign in

Cytomos

4 known investors

Find your way into Cytomos

Cytomos develops AuraCyt®, a microelectronics-based biotechnology platform for real-time single-cell analytics in bioprocessing and cell and gene therapy manufacturing. The company serves large biotech and pharma companies seeking cost-effective process analytical technology solutions for drug development and manufacturing.

BiotechDeep TechMedical Devices

Investors · 4

ArchangelsEdinburgh
British Business BankreportedSheffield
Old College CapitalreportedEdinburgh · $190.5K
Scottish EnterprisereportedGlasgow

In the news

Cytomos Gains $5M for Cell Tech Expansion - Life Science, Pharmaceutical Industry News - Zenopa UKzenopa.com · Nov 2024Cytomos raises $5m to scale up cell analysis technology production - PharmaTimespharmatimes.com · Nov 2024Cytomos raises £5m to advance scalable cell-analysis tech for drug discoverylongevity.technology · Nov 2024Cytomos raises £5M to scale up cell-analysis production - Tech.eutech.eu · Nov 2024Cytomos Raises £5M in Fundingfinsmes.com · Nov 2024

Frequently asked questions

What does Cytomos do?
Cytomos develops AuraCyt®, a microelectronics-based biotechnology platform for real-time single-cell analytics in bioprocessing and cell and gene therapy manufacturing. The company serves large biotech and pharma companies seeking cost-effective process analytical technology solutions for drug development and manufacturing.
Who are Cytomos's investors?
Cytomos's investors include Archangels, British Business Bank, Old College Capital, Scottish Enterprise.